Keywords: skyepharma, astralis, psoriasis, pact, uk, usa, announced

SkyePharma and Astralis in psoriasis pact

Article | 07 January 2002

Print This

SkyePharma of the UK and the USA's Astralis have announced a series ofagreements concerning development of the latter's novel injectable ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in